Key statistics
On Friday, OS Therapies Inc (OSTX:ASQ) closed at 1.86, 17.53% above the 52 week low of 1.58 set on Nov 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.75 |
---|---|
High | 1.94 |
Low | 1.72 |
Bid | 1.73 |
Offer | 2.97 |
Previous close | 1.73 |
Average volume | 35.99k |
---|---|
Shares outstanding | 20.05m |
Free float | 15.50m |
P/E (TTM) | -- |
Market cap | 37.23m USD |
EPS (TTM) | -0.3566 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 01:00 GMT.
More ▼
- OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
- OS Therapies to Present at The Spartan Capital Investor Conference
- Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30
- OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors
- OS Therapies to Present at the LD Micro Main Event XVII
- OS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
- OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Completes Last Patient Visit
- OS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates
- OS Therapies to Present at H.C. Wainright 26th Annual Global Investment Conference
- OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Receives Last Treatment Dose
More ▼